Global changes in cannabis products
As cannabis transitions from an illicit substance to a legal medicine and recreational drug, there have been significant and rapid changes in cannabis products. These include diversification and expansion of products and methods of administration (e.g. “edibles”, “cannabis concentrates”), changes in THC/CBD concentrations in new legal markets (e.g. Washington State) and also illegal markets (e.g. European cannabis resin). The impact of legalisation in Canada is yet to be established, and specific products (edibles and cannabis concentrates) are currently unavailable as legislation is developed. As experiments with cannabis policy and products continue to unfold, it will be crucial to understand their impact from a range of international perspectives. This symposium brings together leading experts from Europe, the USA, Canada and Australia to synthesise the latest developments in cannabis products worldwide. It will be chaired by Dr Tom Freeman and Professor Wayne Hall, who both led commissioned projects on cannabis for the EMCDDA in 2018.